These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36116708)

  • 1. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
    Yang H; Yue GG; Leung PC; Wong CK; Zhang YJ; Lau CB
    Pharmacol Res; 2022 Oct; 184():106457. PubMed ID: 36116708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
    Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH
    Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,3,4,6-Penta-O-galloyl-β-d-glucose suppresses colon cancer through induction of tumor suppressor.
    Kawk SH; Kang YR; Kim YH
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2117-2123. PubMed ID: 29778287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
    Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J
    Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of 1,2,3,4,6-penta-O-galloyl-β-D-glucose in an animal model of lipopolysaccharide-induced pain.
    Chun K; Kim SO; Lee SH
    Int J Mol Med; 2016 Oct; 38(4):1264-70. PubMed ID: 27600119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa aqueous extract in colon cancer via modulation of TGF-β R1-smad2/3-E-cadherin and FAK-RhoA-cofilin pathways.
    Yang H; Yue GG; Yuen KK; Gao S; Leung PC; Wong CK; Lau CB
    Phytomedicine; 2023 Aug; 117():154900. PubMed ID: 37269754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose increases a population of T regulatory cells and inhibits IgE production in ovalbumin-sensitized mice.
    Kim YH; Yang X; Yamashita S; Kumazoe M; Huang Y; Nakahara K; Won YS; Murata M; Lin IC; Tachibana H
    Int Immunopharmacol; 2015 May; 26(1):30-6. PubMed ID: 25737197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG).
    Xiang Q; Tang J; Luo Q; Xue J; Tao Y; Jiang H; Tian J; Fan C
    Biomed Pharmacother; 2019 Mar; 111():813-820. PubMed ID: 30616080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penta-O-galloyl-beta-D-glucose inhibits phorbol myristate acetate-induced interleukin-8 [correction of intereukin-8] gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappaB.
    Oh GS; Pae HO; Choi BM; Lee HS; Kim IK; Yun YG; Kim JD; Chung HT
    Int Immunopharmacol; 2004 Mar; 4(3):377-86. PubMed ID: 15037215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway.
    Kang DG; Moon MK; Choi DH; Lee JK; Kwon TO; Lee HS
    Eur J Pharmacol; 2005 Nov; 524(1-3):111-9. PubMed ID: 16253226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases.
    Mizushina Y; Zhang J; Pugliese A; Kim SH; Lü J
    Biochem Pharmacol; 2010 Oct; 80(8):1125-32. PubMed ID: 20599777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.
    Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J
    Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2,3,4,6-Penta-O-galloyl-d-glucose Interrupts the Early Adipocyte Lifecycle and Attenuates Adiposity and Hepatic Steatosis in Mice with Diet-Induced Obesity.
    Sathyanarayana AR; Lu CK; Liaw CC; Chang CC; Han HY; Green BD; Huang WJ; Huang C; He WD; Lee LC; Liu HK
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hydrolyzable gallotannin, penta-O-galloyl-β-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure.
    Ma H; Liu W; Frost L; Wang L; Kong L; Dain JA; Seeram NP
    Mol Biosyst; 2015 May; 11(5):1338-47. PubMed ID: 25789915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways.
    Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH
    Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
    Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH
    Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of fatty acid synthase by 1,2,3,4,6-penta-O-galloyl-β-D-glucose plays a vital role in anti-tumour activity.
    Zhao W; Wang Y; Hao W; Zhao M; Peng S
    Biochem Biophys Res Commun; 2014 Mar; 445(2):346-51. PubMed ID: 24508804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes.
    Liu X; Malki A; Cao Y; Li Y; Qian Y; Wang X; Chen X
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):308-16. PubMed ID: 25988880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1.
    Hu H; Zhang J; Lee HJ; Kim SH; Lü J
    Carcinogenesis; 2009 May; 30(5):818-23. PubMed ID: 19269999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penta-O-galloyl-β-D-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in Caki-2 renal cancer cells.
    Ryu HG; Jeong SJ; Kwon HY; Lee HJ; Lee EO; Lee MH; Choi SH; Ahn KS; Kim SH
    Toxicol In Vitro; 2012 Mar; 26(2):206-14. PubMed ID: 22172427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.